X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
hematology (9) 9
humans (9) 9
oncology (9) 9
female (8) 8
male (8) 8
aged (7) 7
middle aged (7) 7
leukemia (6) 6
prognosis (6) 6
adult (5) 5
aged, 80 and over (5) 5
chronic myeloid leukemia (5) 5
chronic myeloid-leukemia (5) 5
disease-free survival (5) 5
imatinib (5) 5
myeloid leukemia (5) 5
survival (5) 5
analysis (4) 4
foxm1 (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
800 mg (3) 3
adolescent (3) 3
care and treatment (3) 3
cell biology (3) 3
end-points (3) 3
follow-up (3) 3
gene expression (3) 3
interferon (3) 3
kaplan-meier estimate (3) 3
kinase inhibitor optimization (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - mortality (3) 3
patients (3) 3
progression-free survival (3) 3
recommendations (3) 3
remission (3) 3
remission induction (3) 3
survival prediction (3) 3
validation (3) 3
young adult (3) 3
antineoplastic agents - administration & dosage (2) 2
artificial gene amplification and extension (2) 2
biology and life sciences (2) 2
biomarker (2) 2
biomarkers (2) 2
bladder cancer (2) 2
cancer (2) 2
cancer research (2) 2
cancers and neoplasms (2) 2
chromosomal aberrations (2) 2
chromosomal translocations (2) 2
chromosome biology (2) 2
chronic myeloid leukaemia (2) 2
cytogenetics (2) 2
dasatinib (2) 2
data processing (2) 2
deeper molecular responses (2) 2
diagnosed chronic-phase (2) 2
diagnosis (2) 2
diagnostic medicine (2) 2
disease progression (2) 2
expression (2) 2
forkhead box protein m1 - genetics (2) 2
forkhead protein (2) 2
fusion proteins, bcr-abl - genetics (2) 2
gene expression profiling (2) 2
health aspects (2) 2
hematologic cancers and related disorders (2) 2
history (2) 2
human migration (2) 2
imatinib mesylate - therapeutic use (2) 2
institut für medizinische informationsverarbeitung, biometrie und epidemiologie (2) 2
invasiveness (2) 2
ki67 (2) 2
kinases (2) 2
labor migration (2) 2
laboratories (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - therapy (2) 2
leukemias (2) 2
management (2) 2
mediates resistance (2) 2
medicine & public health (2) 2
medicine and health sciences (2) 2
molecular biology (2) 2
molecular biology techniques (2) 2
molecular subtypes (2) 2
monitoring (2) 2
multidisciplinary sciences (2) 2
muscle invasive bladder cancer (2) 2
myeloproliferative disorders (2) 2
neoplasm staging (2) 2
occlusive disease (2) 2
patients receiving imatinib (2) 2
polymerase chain reaction (2) 2
proportional hazards models (2) 2
protein kinase inhibitors - administration & dosage (2) 2
quality control (2) 2
randomization (2) 2
research (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 03/2019, Volume 14, Issue 3, p. e0214305
Journal Article
Quaderni d'Italianistica, ISSN 0226-8043, 2017, Volume 38, Issue 1, pp. 85 - 107
This contribution proposes to reflect on the experience and sense of identity of Italians through the analysis of Il Lavoratore Italiano, an Italian-language... 
LITERATURE, ROMANCE | periodicals | Il Lavoratore Italiano | Italian language literature | 1900-1999 | Italian immigrant experience | Italian American identity | American literature
Journal Article
BJU International, ISSN 1464-4096, 01/2019, Volume 123, Issue 1, pp. 187 - 196
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2015, Volume 94, Issue 12, pp. 2015 - 2024
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 9/2018, Volume 144, Issue 9, pp. 1701 - 1709
The proto-oncogene forkhead box M1 (FOXM1) is associated with poor survival in many cancers. The impact of FOXM1 expression on progression-free survival (PFS)... 
Molecular subtypes | Biomarker | Medicine & Public Health | Hematology | Oncology | Cancer Research | Internal Medicine | FOXM1 | MKI67 | Progression-free survival | Bladder cancer | CELLS | ONCOLOGY | SUBTYPES | UROTHELIAL CARCINOMA | EXPRESSION | Original – Cancer Research
Journal Article
Leukemia, ISSN 0887-6924, 05/2015, Volume 29, Issue 5, pp. 1123 - 1132
Tyrosine kinase inhibitors (TKI) have changed the natural course of chronic myeloid leukemia (CML). With the advent of secondgeneration TKI safety and efficacy... 
MANAGEMENT | OCCLUSIVE DISEASE | ONCOLOGY | KINASE INHIBITOR OPTIMIZATION | DIAGNOSED CHRONIC-PHASE | 800 MG | FOLLOW-UP | END-POINTS | PATIENTS RECEIVING IMATINIB | HEMATOLOGY | DEEPER MOLECULAR RESPONSES | CHRONIC MYELOID-LEUKEMIA | Piperazines - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Benzamides - administration & dosage | Antineoplastic Agents - adverse effects | Female | Benzamides - adverse effects | Pyrimidines - administration & dosage | Interferon-alpha - therapeutic use | Treatment Outcome | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Disease Progression | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Pilot Projects | Pyrimidines - adverse effects | Aged | Fusion Proteins, bcr-abl - metabolism | Antimitotic agents | Care and treatment | Usage | Cytogenetics | Chronic myeloid leukemia | Diagnosis | Antineoplastic agents | Health aspects | Tyrosine | Depth indicators | Imatinib | Toxicity | Myeloid leukemia | Leukemia | Kinases | Survival | α-Interferon | Side effects | Randomization | Remission | Interferon | Safety | Protein-tyrosine kinase | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 05/2018, Volume 32, Issue 5, pp. 1222 - 1228
Journal Article
Leukemia, ISSN 0887-6924, 11/2017, Volume 31, Issue 11, pp. 2398 - 2406
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 04/2018, Volume 18, Issue 4, pp. 266 - 271
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 40, pp. 25935 - 25945
Transcriptome expression studies identified distinct muscle invasive bladder cancer (MIBC) subtypes closely related with breast cancer subclasses. Here we... 
Biomarkers | Survival prediction | Bladder cancer subtypes | Drug targets | Gene expression
Journal Article